Cargando…

PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target

Chronic Lymphocytic Leukaemia (CLL) is the most common adult B‐cell leukaemia and despite improvement in patients' outcome, following the use of targeted therapies, it remains incurable. CLL supportive microenvironment plays a key role in both CLL progression and drug resistance through signals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sbrana, Francesca Vittoria, Fiordi, Benedetta, Bordini, Jessica, Belloni, Daniela, Barbaglio, Federica, Russo, Luca, Scarfò, Lydia, Ghia, Paolo, Scielzo, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930416/ https://www.ncbi.nlm.nih.gov/pubmed/36747338 http://dx.doi.org/10.1111/jcmm.17688

Ejemplares similares

Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents
por: Barbaglio, Federica, et al.
Publicado: (2020)

3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells
por: Sbrana, Francesca Vittoria, et al.
Publicado: (2021)

Establishment and Characterization of PCL12, a Novel CD5(+) Chronic Lymphocytic Leukaemia Cell Line
por: Agathangelidis, Andreas, et al.
Publicado: (2015)

Correction: Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line
por: Agathangelidis, Andreas, et al.
Publicado: (2015)

Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system
por: Belloni, Daniela, et al.
Publicado: (2022)

Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia
por: McMahon, Kaylin M., et al.
Publicado: (2017)

EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine
por: Valsecchi, Roberta, et al.
Publicado: (2020)

3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B Cells
por: Sampietro, Marta, et al.
Publicado: (2021)

Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia
por: Minici, Claudia, et al.
Publicado: (2017)

Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models
por: Bianco, Mimma, et al.
Publicado: (2016)

What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice Experiment
por: Laurenti, Luca, et al.
Publicado: (2022)

P1489: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Bordini, Jessica, et al.
Publicado: (2023)

The Nanomechanical Properties of CLL Cells Are Linked to the Actin Cytoskeleton and Are a Potential Target of BTK Inhibitors
por: Sampietro, Marta, et al.
Publicado: (2023)

Modeling the Leukemia Microenviroment In Vitro
por: Scielzo, Cristina, et al.
Publicado: (2020)

BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia
por: Fiorcari, Stefania, et al.
Publicado: (2020)

Pyk2 for perfect bones
por: LeBrasseur, Nicole
Publicado: (2007)

Assessing Patients’ Knowledge on Chronic Lymphocytic Leukemia: Validation of the ERIC CLL Knowledge Questionnaire in Greece
por: Karamanidou, Christina, et al.
Publicado: (2021)

Role of Pyk2 in Human Cancers
por: Shen, Ting, et al.
Publicado: (2018)

Impact of the Whole Genome Duplication Event on PYK Activity and Effects of a PYK1 Mutation on Metabolism in S. cerevisiae
por: Chen, Hong, et al.
Publicado: (2021)

Convergent Effects of Resveratrol and PYK2 on Prostate Cells
por: Conte, Andrea, et al.
Publicado: (2016)

Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency
por: Rigolin, Gian Matteo, et al.
Publicado: (2023)

Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Herishanu, Yair, et al.
Publicado: (2022)

Proline-rich tyrosine kinase Pyk2 regulates deep vein thrombosis
por: Momi, Stefania, et al.
Publicado: (2022)

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Time to Retire?
por: Scarfò, Lydia, et al.
Publicado: (2019)

Pyk2 overexpression in postsynaptic neurons blocks amyloid β(1–42)-induced synaptotoxicity in microfluidic co-cultures
por: Kilinc, Devrim, et al.
Publicado: (2020)

Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations
por: Agathangelidis, Andreas, et al.
Publicado: (2018)

Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells
por: Fonte, Eleonora, et al.
Publicado: (2017)

Novel Role of Src in Priming Pyk2 Phosphorylation
por: Zhao, Ming, et al.
Publicado: (2016)

PYK2 at the Intersection of Signaling Pathways in Pancreatic Cancer
por: Means, Anna L.
Publicado: (2019)

A Case of Lymphocytic Leukæmia
por: Reynolds, Fredrick H.
Publicado: (1933)

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
por: Herishanu, Yair, et al.
Publicado: (2021)

Infrequent “chronic lymphocytic leukemia-specific” immunoglobulin stereotypes in aged individuals with or without low-count monoclonal B-cell lymphocytosis
por: Agathangelidis, Andreas, et al.
Publicado: (2021)

A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression
por: Farinello, Diego, et al.
Publicado: (2018)

Suppression of Pyk2 Kinase and Cellular Activities by Fip200
por: Ueda, Hiroki, et al.
Publicado: (2000)

Pyk2 promotes tumor progression in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2018)

Pyk2 Regulates MAMs and Mitochondrial Dynamics in Hippocampal Neurons
por: López-Molina, Laura, et al.
Publicado: (2022)

Seasonality in the diagnosis of acute lymphocytic leukaemia.
por: Badrinath, P., et al.
Publicado: (1997)

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
por: Freeman, Ciara L., et al.
Publicado: (2016)

Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies
por: Bordini, Jessica, et al.
Publicado: (2020)

Computational analysis of the evolutionarily conserved Missing In Metastasis/Metastasis Suppressor 1 gene predicts novel interactions, regulatory regions and transcriptional control
por: Petrov, Petar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vqun7r7g4c528rlltsib85u700